Florian Schindhelm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Florian Schindhelm has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Amir Abbas Mahabadi
University Hospital Essen, University of Duisburg-Essen, West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, Essen, Germany
4 shared publications Christoph Alexander Mues
Medical Clinic I, Department of Cardiology, St. Johannes Hospital, Dortmund, Germany
3 shared publicationsDonika Mustafa
Department of Cardiology, Heart Center, Faculty of Medicine, University of Cologne, Cologne, Germany; Center for Cardiovascular Medicine ABCD, Aachen - Bonn - Cologne - Düsseldorf, Germany
3 shared publications- Guido Ascione
Cardiovascular Research Foundation
3 shared publications - Henning Guthoff
Department of Cardiology, Heart Center, Faculty of Medicine, University of Cologne, Cologne, Germany; Center for Cardiovascular Medicine ABCD, Aachen - Bonn - Cologne - Düsseldorf, Germany
3 shared publications Jannik Jobst
Department of Cardiology and Angiology, Justus-Liebig-University Giessen, Giessen, Germany
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Long-Term Outcomes After Contemporary High-Risk Percutaneous Coronary Intervention: A Risk-Adapted Approach
Introduction: High-risk percutaneous coronary intervention (HRPCI) is increasingly performed in patients with complex coronary artery disease. However, long-term outcome data remain limited, particularly across different procedural risk categories.Objectives: To evaluate in-hospital and long-term outcomes following HRPCI according to procedural risk categories and to identify factors associated with long-term mortality.Methods: We retrospectively analysed 671 consecutive HRPCI procedures performed between 2016 and 2023 at our tertiary university-centre. Procedures were categorized according to the validated high-risk intervention (HRI) classification (HRI I–III), with prophylactic Impella support in HRI III. Factors associated with 5-year mortality were identified using multivariable Cox regression analysis.Results: In-hospital major adverse cardiac and cerebrovascular events (MACCE) and mortality were low (3.7% and 2.2%). Kaplan–Meier estimated all-cause mortality was 9.9% at 1 year, 15.5% at 2 years and 27.5% at 5 years. In patients with prophylactic Impella support, mortality was 16.5% at 1 year, 18.4% at 2 years and 25.7% at 5 years. Despite increasing procedural complexity, 5-year survival did not differ significantly across HRI categories (log-rank p = 0.863). Multivariable Cox regression identified age, male sex, diabetes mellitus, chronic kidney disease (CKD stage ≥4), anaemia and impaired left ventricular systolic function (≤40%) as factors independently associated with 5-year mortality, whereas HRI category was not.Conclusion: Within a risk-adapted treatment strategy, contemporary HRPCI was associated with favourable in-hospital outcomes. Despite increasing procedural complexity, no statistically significant differences in long-term survival were observed across HRI categories. Long-term prognosis was primarily determined by patients’ baseline risk profile rather than procedural complexity.
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLong-Term Outcomes After Contemporary High-Risk Percutaneous Coronary Intervention: A Risk-Adapted Approach
Introduction: High-risk percutaneous coronary intervention (HRPCI) is increasingly performed in patients with complex coronary artery disease. However, long-term outcome data remain limited, particularly across different procedural risk categories.Objectives: To evaluate in-hospital and long-term outcomes following HRPCI according to procedural risk categories and to identify factors associated with long-term mortality.Methods: We retrospectively analysed 671 consecutive HRPCI procedures performed between 2016 and 2023 at our tertiary university-centre. Procedures were categorized according to the validated high-risk intervention (HRI) classification (HRI I–III), with prophylactic Impella support in HRI III. Factors associated with 5-year mortality were identified using multivariable Cox regression analysis.Results: In-hospital major adverse cardiac and cerebrovascular events (MACCE) and mortality were low (3.7% and 2.2%). Kaplan–Meier estimated all-cause mortality was 9.9% at 1 year, 15.5% at 2 years and 27.5% at 5 years. In patients with prophylactic Impella support, mortality was 16.5% at 1 year, 18.4% at 2 years and 25.7% at 5 years. Despite increasing procedural complexity, 5-year survival did not differ significantly across HRI categories (log-rank p = 0.863). Multivariable Cox regression identified age, male sex, diabetes mellitus, chronic kidney disease (CKD stage ≥4), anaemia and impaired left ventricular systolic function (≤40%) as factors independently associated with 5-year mortality, whereas HRI category was not.Conclusion: Within a risk-adapted treatment strategy, contemporary HRPCI was associated with favourable in-hospital outcomes. Despite increasing procedural complexity, no statistically significant differences in long-term survival were observed across HRI categories. Long-term prognosis was primarily determined by patients’ baseline risk profile rather than procedural complexity.
- Open Access
- 25 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (8) , 103014
Small Mitral Valve Orifice Area in Mitral Valve Transcatheter Edge-to-Edge Repair
- 25 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (8) , 103014
Open AccessSmall Mitral Valve Orifice Area in Mitral Valve Transcatheter Edge-to-Edge Repair
- Open Access
- 14 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102782
Sex-Specific Outcomes in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair
- 14 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102782
Open AccessSex-Specific Outcomes in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair
- 1 November 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (11) , e015845
Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair
BACKGROUND: Residual mitral regurgitation (rMR) ≤1+ has been associated with improved 1-year outcomes after mitral valve transcatheter edge-to-edge repair, regardless of the mean mitral pressure gradient (MPG). Prior evidence is limited to 30-day echocardiographic follow-up and patients treated with the MitraClip (Abbott Structural Heart). Whether rMR and MPG assessed at discharge are associated with outcomes after PASCAL mitral valve transcatheter edge-to-edge repair (Edwards Lifesciences) remains unknown. METHODS: REPAIR (Registry of Pascal for Mitral Regurgitation) is an investigator-initiated, multicenter registry including all consecutive patients treated with PASCAL mitral valve transcatheter edge-to-edge repair. Based on discharge echocardiography, patients were stratified into 4 groups: optimal (rMR ≤1+, MPG P P Bonferroni P <0.001) and remained significant, independent of dichotomized (MPG, 0.450). CONCLUSIONS: Discharge rMR ≤1+ is independently associated with lower 1-year mortality after PASCAL mitral valve transcatheter edge-to-edge repair. Although MPG was not independently associated, modestly elevated gradients may be acceptable when rMR ≤1+ is achieved, but should still warrant clinical attention. REGISTRATION: URL: https://www.drks.de ; Unique identifier: DRKS00033959.
- 1 November 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (11) , e015845
Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair
BACKGROUND: Residual mitral regurgitation (rMR) ≤1+ has been associated with improved 1-year outcomes after mitral valve transcatheter edge-to-edge repair, regardless of the mean mitral pressure gradient (MPG). Prior evidence is limited to 30-day echocardiographic follow-up and patients treated with the MitraClip (Abbott Structural Heart). Whether rMR and MPG assessed at discharge are associated with outcomes after PASCAL mitral valve transcatheter edge-to-edge repair (Edwards Lifesciences) remains unknown. METHODS: REPAIR (Registry of Pascal for Mitral Regurgitation) is an investigator-initiated, multicenter registry including all consecutive patients treated with PASCAL mitral valve transcatheter edge-to-edge repair. Based on discharge echocardiography, patients were stratified into 4 groups: optimal (rMR ≤1+, MPG P P Bonferroni P <0.001) and remained significant, independent of dichotomized (MPG, 0.450). CONCLUSIONS: Discharge rMR ≤1+ is independently associated with lower 1-year mortality after PASCAL mitral valve transcatheter edge-to-edge repair. Although MPG was not independently associated, modestly elevated gradients may be acceptable when rMR ≤1+ is achieved, but should still warrant clinical attention. REGISTRATION: URL: https://www.drks.de ; Unique identifier: DRKS00033959.
- 26 September 2023
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (1) , 339-347
Measurement of peripheral arterial tone to detect sleep-disordered breathing in patients with heart failure
Purpose Sleep-disordered breathing is highly prevalent in patients with heart failure and is related to increased mortality and morbidity. The gold standard for sleep diagnostic is polysomnography in a sleep laboratory. Measurement of peripheral arterial tone with a wrist-worn diagnostic device is a promising method to detect sleep-disordered breathing without major technical effort. Methods We prospectively enrolled patients with heart failure with reduced ejection fraction for measurement of the peripheral arterial tone and polysomnography simultaneously during one night in the sleep laboratory. Raw data of polysomnography was analyzed blindly by sleep core lab personnel and compared with automatic algorithm-based sleep results of measurement of the peripheral arterial tone. Results A total of 25 patients provided comparable sleep results. All patients had sleep-disordered breathing and were identified by measurement of the peripheral arterial tone. The comparison of apnea-hypopnea index between peripheral arterial tone 38.8 ± 17.4/h and polysomnography 44.5 ± 17.9/h revealed a bias of − 5.7 ± 9.8/h with limits of agreement of ± 19.2/h in Bland-Altman analysis but showed high and significant Pearson correlation (r = 0.848, p < 0.001). Conclusion The findings suggest that measurement of the peripheral arterial tone may be useful to identify sleep-disordered breathing in patients with heart failure with reduced ejection fraction.
- 26 September 2023
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (1) , 339-347
Measurement of peripheral arterial tone to detect sleep-disordered breathing in patients with heart failure
Purpose Sleep-disordered breathing is highly prevalent in patients with heart failure and is related to increased mortality and morbidity. The gold standard for sleep diagnostic is polysomnography in a sleep laboratory. Measurement of peripheral arterial tone with a wrist-worn diagnostic device is a promising method to detect sleep-disordered breathing without major technical effort. Methods We prospectively enrolled patients with heart failure with reduced ejection fraction for measurement of the peripheral arterial tone and polysomnography simultaneously during one night in the sleep laboratory. Raw data of polysomnography was analyzed blindly by sleep core lab personnel and compared with automatic algorithm-based sleep results of measurement of the peripheral arterial tone. Results A total of 25 patients provided comparable sleep results. All patients had sleep-disordered breathing and were identified by measurement of the peripheral arterial tone. The comparison of apnea-hypopnea index between peripheral arterial tone 38.8 ± 17.4/h and polysomnography 44.5 ± 17.9/h revealed a bias of − 5.7 ± 9.8/h with limits of agreement of ± 19.2/h in Bland-Altman analysis but showed high and significant Pearson correlation (r = 0.848, p < 0.001). Conclusion The findings suggest that measurement of the peripheral arterial tone may be useful to identify sleep-disordered breathing in patients with heart failure with reduced ejection fraction.